Pharmiza Drugs Private Limited - Company Profile

It is a healthcare private limited company based in Indore, Madhya Pradesh, India, established in 2022.
2022 Indore, Madhya Pradesh, India Active
Last Updated:
Access Report
About Pharmiza Drugs Private Limited

Pharmiza Drugs Private Limited, a active private limited company, was established on 29 September 2022 in Indore, Madhya Pradesh, India. Engaging in manufacturing within the healthcare sector, it holds CIN: U33100MP2022PTC062919. Registered under ROC Roc Gwalior. it is unlisted. It has an authorized capital of ₹1.50 M and a paid-up capital of ₹0.10 M.

Its leadership includes Khalid Sheikh (Director), Aves Pathan (Director), Shakib Pathan (Director). Past directors included Naved Khan, Mazhar Agwan. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 6, Deep Palace Colony,, Pipliya Kumar,, Indore, Madhya Pradesh, 452010.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U33100MP2022PTC062919

  • Registration Number

    062919

  • Incorporation Date

    29 September 2022

  • Authorized Capital

    ₹1.50 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Gwalior

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.50 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 3 Year, 4 Months
  • Last Filing with ROC 31 Mar 2025
Company report

Pharmiza Drugs Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Pharmiza Drugs Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Pharmiza Drugs Private Limited?
Current Directors
Name Designation Appointment Date Status
Khalid Sheikh Director 29 Sep 2022 Current
Aves Pathan Director 29 Sep 2022 Current
Shakib Pathan Director 29 Sep 2022 Current
Mazhar Agwan Director 27 Oct 2022 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 18 Dec 2023 Past
Pramod Abcsdd Additional Director 29 Dec 2023 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Pharmiza Drugs.

Enhance accessibility to Pharmiza Drugs's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Pharmiza Drugs revenue growth over time
Pharmiza Drugs profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Pharmiza Drugs?

Unlock access to Pharmiza Drugs's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Pharmiza Drugs?

Pharmiza Drugs has a workforce of 0 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Pharmiza Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pharmiza Drugs's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Pharmiza Drugs
Recent Activity within the Organization
  • Annual General Meeting

    Pharmiza Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    Pharmiza Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Gwalior. was recorded as a recent event.

  • Director Appointment

    Progress on Mazhar Agwan was appointed as a Director was appointed as a Director on 27 Oct 2022 & has been associated with this company since 3 years 3 months . was documented.

  • Director Appointment

    The activity Khalid Sheikh was appointed as a Director was appointed as a Director on 29 Sep 2022 & has been associated with this company since 3 years 4 months . was completed.

  • Director Appointment

    Progress on Aves Pathan was appointed as a Director was appointed as a Director on 29 Sep 2022 & has been associated with this company since 3 years 4 months . was documented.

  • Director Appointment

    Shakib Pathan was appointed as a Director was appointed as a Director on 29 Sep 2022 & has been associated with this company since 3 years 4 months . was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Pharmiza Drugs Private Limited?

The CIN of Pharmiza Drugs Private Limited is U33100MP2022PTC062919.

Where is Pharmiza Drugs Private Limited headquartered?

Pharmiza Drugs Private Limited is headquartered at 6, Deep Palace Colony,, Pipliya Kumar,, Indore, Madhya Pradesh, 452010.

When was Pharmiza Drugs Private Limited incorporated?

Pharmiza Drugs Private Limited was incorporated on 29 September 2022.

Who are the current directors of Pharmiza Drugs Private Limited?

The current directors of Pharmiza Drugs Private Limited are

What is the primary industry of Pharmiza Drugs Private Limited?

The primary industry of Pharmiza Drugs Private Limited is Healthcare.

Is Pharmiza Drugs Private Limited a listed company?

Pharmiza Drugs Private Limited is unlisted.

What is the capital structure of Pharmiza Drugs Private Limited?

The authorized capital of Pharmiza Drugs Private Limited is ₹1.50 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available